Picture of Newbury Pharmaceuticals AB logo

NEWBRY — Newbury Pharmaceuticals AB News Story

0.000.00%
se flag iconLast trade - 00:00
Consumer DefensivesHighly SpeculativeMicro CapMomentum Trap

Brief: Newbury Pharmaceuticals Q3 EBITDA Loss Widens To SEK 7.9 Mln

July 10 (Reuters) - Newbury Pharmaceuticals AB
 NEWBRY.ST :
    * Q3 NET REVENUE WAS SEK 1.4 MILLION VERSUS SEK 5.7 MILLION
YEAR
AGO
    * Q3 EBITDA LOSS SEK 7.9 MILLION VERSUS LOSS SEK 3.9 MILLION
YEAR
AGO

Source text for Eikon:  ID:nMFNbPBTg9 
Further company coverage:  NEWBRY.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on Newbury Pharmaceuticals AB

See all news